Cargando…

Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis

BACKGROUND AND AIMS: This study aimed to estimate the preferences for COVID‐19 vaccines among a sample of Iranian adults and to understand the sources of preference heterogeneity. METHODS: A web‐based survey was conducted from April to July 2021; out of 1747 participants, 678 completed the survey. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvizi, Sanaz, Mehrara, Mohsen, Taiebnia, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259456/
https://www.ncbi.nlm.nih.gov/pubmed/37313535
http://dx.doi.org/10.1002/hsr2.1332
_version_ 1785057665364262912
author Parvizi, Sanaz
Mehrara, Mohsen
Taiebnia, Ali
author_facet Parvizi, Sanaz
Mehrara, Mohsen
Taiebnia, Ali
author_sort Parvizi, Sanaz
collection PubMed
description BACKGROUND AND AIMS: This study aimed to estimate the preferences for COVID‐19 vaccines among a sample of Iranian adults and to understand the sources of preference heterogeneity. METHODS: A web‐based survey was conducted from April to July 2021; out of 1747 participants, 678 completed the survey. Seven key attributes were selected, namely effectiveness, risk of severe side effects, risk of mild side effects, number of doses, duration of protection, location of manufacture, and price. Additionally, conditional logit and mixed logit models were used to analyze the data. RESULTS: The results of this study indicate that vaccine effectiveness, protective duration, the risk of side effects, and price are the most important factors that influence vaccine preferences. Furthermore, we identified heterogeneity in preferences, indicating that not all individuals respond in the same way to vaccine attributes. CONCLUSION: The majority of Iranians prefer to get the Covid‐19 vaccine. Policymakers should consider these findings when implementing successful programs. This study contributes to the literature by estimating Iranian respondents' preferences for the Covid‐19 vaccine and identifying the heterogeneity in their preferences for vaccine attributes. The findings may also inform future research and policies related to Covid‐19 vaccination programs in Iran.
format Online
Article
Text
id pubmed-10259456
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102594562023-06-13 Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis Parvizi, Sanaz Mehrara, Mohsen Taiebnia, Ali Health Sci Rep Original Research BACKGROUND AND AIMS: This study aimed to estimate the preferences for COVID‐19 vaccines among a sample of Iranian adults and to understand the sources of preference heterogeneity. METHODS: A web‐based survey was conducted from April to July 2021; out of 1747 participants, 678 completed the survey. Seven key attributes were selected, namely effectiveness, risk of severe side effects, risk of mild side effects, number of doses, duration of protection, location of manufacture, and price. Additionally, conditional logit and mixed logit models were used to analyze the data. RESULTS: The results of this study indicate that vaccine effectiveness, protective duration, the risk of side effects, and price are the most important factors that influence vaccine preferences. Furthermore, we identified heterogeneity in preferences, indicating that not all individuals respond in the same way to vaccine attributes. CONCLUSION: The majority of Iranians prefer to get the Covid‐19 vaccine. Policymakers should consider these findings when implementing successful programs. This study contributes to the literature by estimating Iranian respondents' preferences for the Covid‐19 vaccine and identifying the heterogeneity in their preferences for vaccine attributes. The findings may also inform future research and policies related to Covid‐19 vaccination programs in Iran. John Wiley and Sons Inc. 2023-06-12 /pmc/articles/PMC10259456/ /pubmed/37313535 http://dx.doi.org/10.1002/hsr2.1332 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Parvizi, Sanaz
Mehrara, Mohsen
Taiebnia, Ali
Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis
title Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis
title_full Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis
title_fullStr Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis
title_full_unstemmed Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis
title_short Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis
title_sort investigating preferences of the covid‐19 vaccine among individuals in iran: discrete choice experiment analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259456/
https://www.ncbi.nlm.nih.gov/pubmed/37313535
http://dx.doi.org/10.1002/hsr2.1332
work_keys_str_mv AT parvizisanaz investigatingpreferencesofthecovid19vaccineamongindividualsinirandiscretechoiceexperimentanalysis
AT mehraramohsen investigatingpreferencesofthecovid19vaccineamongindividualsinirandiscretechoiceexperimentanalysis
AT taiebniaali investigatingpreferencesofthecovid19vaccineamongindividualsinirandiscretechoiceexperimentanalysis